# @newsday on Instagram

- **Type:** Image
- **Original URL:** https://www.instagram.com/p/DXpWTWzlDk3
- **Gondola URL:** https://gondola.cc/posts/64823369-newsday-instagram
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/dfee464d76.jpg
- **Posted:** 2026-04-27T19:00:35.000+00:00
- **Account Owner:** Newsday • Long Island News (@newsday) — https://gondola.cc/newsday

## Caption

Christina Amitrano considers herself lucky that her breast cancer was discovered at the age of 35. So after two years of aggressive treatment, she enrolled in a clinical trial of an experimental vaccine doctors hope will reduce the risk of her cancer's recurrence.

Stony Brook Cancer Center is one of 160 sites worldwide participating in the FLAMINGO-01 Phase III clinical trial by Greenwich LifeSciences, a biopharmaceutical company based in Texas. It’s a tumor vaccine specific for people diagnosed with HER2-positive breast cancer.

Read the full story at the link in bio. (Photos: John Paraskevas)
-
-
#longislandny #stonybrook #cancer #breastcancer #vaccine

## Stats

- **Views:** 0
- **Likes:** 155
- **Shares:** 0
- **Comments:** 2

## Tags

cancer, stonybrook, breastcancer, vaccine, longislandny

---
Copyright (c) Gondola